HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ASCLETIS-B

9.450

-0.600-5.97%

Volume:3.98M

Turnover:38.67M

Market Cap:9.94B

PE:-21.84

High:10.130

Open:9.585

Low:9.450

Close:10.050

52wk High:19.860

52wk Low:7.950

Shares:1.05B

HK Float Shares:1.05B

Volume Ratio:1.08

T/O Rate:0.38%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-0.433

ROE:-28.59%

ROA:-19.64%

PB:3.74

PE(LYR):-21.84

PS:8979.38

Loading ...

Overview Company News Filings

Sagimet Biosciences Shares Rise With Focus on Acne Treatment

ASCLETIS-B Completes Patient Enrollment for US Phase II Trial of Oral GLP-1R Agonist ASC30 in Diabetes

Ascletis Completes Enrollment in U.S. Phase Ii Study of Asc30, an Oral Small Molecule Glp-1R Agonist, for the Treatment of Diabetes

THOMSON REUTERS

Ascletis completes enrollment in US Phase II diabetes trial of oral GLP-1 drug ASC30

ASCLETIS-B Shares Surge Over 4% in Morning Session as Key Pipeline Drug ASC30 Nears Phase III Trial

HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%

Tiger Newspress

Assessing Ascletis Pharma (SEHK:1672) Valuation After ASC30_39 Obesity Candidate Advances Toward FDA IND Filing

Simply Wall St.

ASCLETIS-B Nears Previous Peak, But Why Are Investors Staying on the Sidelines?

ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials

Analysts Are Optimistic We'll See A Profit From Ascletis Pharma Inc. (HKG:1672)

Simply Wall St.

ASCLETIS-B Maintains Stable Share Base in March; No New Issuance, Public Float Fully Compliant

Bulletin Express

ASCLETIS-B Advances Clinical Development of Fixed-Dose Combination ASC30_39 for Obesity Treatment

BRIEF-Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development

Ascletis Accelerates Obesity Pipeline with First-in-Class Oral GLP-1/Amylin Fixed-Dose Combo; IND Targeted for Q3 2026

Bulletin Express

Ascletis Pharma Inc - Expects Ind Submission to FDA for Asc30_39 Fdc in Q3 2026

THOMSON REUTERS

Ascletis targets Q3 2026 FDA IND filing for oral obesity combo ASC30_39 tablet

Ascletis Pharma's Loss Widens 20% in 2025; Shares Rise 5%

MT Newswires Live

BRIEF-Ascletis Pharma FY Loss Attributable Rmb359.9 Million

ASCLETIS-B Reports Annual Loss Attributable to Shareholders of 360 Million Yuan, Widening 19.6% Year-on-Year

Ascletis Pharma Inc - FY Loss Attributable RMB359.9 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/stock/01672/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"01672","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","market":"HK","secType":"STK","nameCN":"ASCLETIS-B","latestPrice":9.45,"timestamp":1789114135004,"preClose":10.05,"halted":0,"volume":3977700,"delay":0,"changeRate":-0.05970149253731357,"floatShares":1052000000,"shares":1052000000,"eps":-0.4326865354299831,"marketStatus":"Market Closed","change":-0.6,"latestTime":"09-11 16:08:55","open":9.585,"high":10.13,"low":9.45,"amount":38668317,"amplitude":0.067662,"askPrice":9.465,"askSize":2000,"bidPrice":9.45,"bidSize":61000,"shortable":3,"etf":0,"ttmEps":-0.6838890693619858,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789349400000},"marketStatusCode":7,"adr":0,"listingDate":1533052800000,"exchange":"SEHK","adjPreClose":10.05,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"volumeRatio":1.081747,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01672\",,,,,undefined,":{"symbol":"01672","floatShares":1052000000,"roa":"-19.64%","roe":"-28.59%","lyrEps":-0.432684,"volumeRatio":1.081747,"shares":1052000000,"dividePrice":0,"high":10.13,"amplitude":0.067662,"preClose":10.05,"low":9.45,"week52Low":7.95,"pbRate":"3.74","psRate":"8979.38","week52High":19.86,"institutionHeld":0,"latestPrice":9.45,"committee":0.936508,"eps":-0.4326836327987137,"divideRate":0,"volume":3977700,"delay":0,"ttmEps":-0.6838844815654288,"open":9.585,"prevYearClose":11.39,"prevWeekClose":10.09,"prevMonthClose":10.02,"prevQuarterClose":10.56,"fiveDayClose":10.09,"twentyDayClose":10.55,"sixtyDayClose":9.91},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01672\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null},{"market":"HK","date":"2026-03-31","symbol":"01672","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774886400000,"reportTimeType":"post","actualEps":null},{"date":"2025-08-15","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755221400000,"name":null,"time":"","dateTimestamp":1755187200000,"actualEps":null},{"date":"2025-03-26","symbol":"01672","type":"earning","reportTimeType":"pre","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742952600000,"name":null,"time":"Pre-MKt","dateTimestamp":1742918400000,"actualEps":null},{"date":"2024-08-30","symbol":"01672","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01672\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01672\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.6667,"buy":0,"hold":0.3333,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0,"analysts":3,"updateTime":1749830400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01672\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01672","date":"2026-09-10","current":-13.820969,"percent":0.491443,"low":-64.074951,"twenty":-27.063443,"median":-15.125792,"eighty":-7.027235,"high":-3.060869,"avg":-18.687848,"sd":13.884275,"marketCap":10616074742},"quantilePoints":[{"date":"2021-09-17","current":-9.347674,"twenty":-26.710974,"median":-15.066642,"eighty":-12.561454,"marketCap":3021650500},{"date":"2021-09-24","current":-9.343351,"twenty":-26.698392,"median":-15.042421,"eighty":-12.475139,"marketCap":3021650500},{"date":"2021-09-30","current":-8.973563,"twenty":-26.689048,"median":-14.919568,"eighty":-12.420739,"marketCap":2911772300},{"date":"2021-10-08","current":-9.244464,"twenty":-26.640258,"median":-14.827353,"eighty":-12.337134,"marketCap":2999538360},{"date":"2021-10-15","current":-9.166534,"twenty":-26.60885,"median":-14.642735,"eighty":-12.284716,"marketCap":2976292730},{"date":"2021-10-22","current":-9.46655,"twenty":-26.590594,"median":-14.417378,"eighty":-12.067263,"marketCap":3095773440},{"date":"2021-10-29","current":-9.149748,"twenty":-26.550486,"median":-14.330599,"eighty":-10.167628,"marketCap":2984772960},{"date":"2021-11-05","current":-8.624888,"twenty":-26.516254,"median":-14.241832,"eighty":-9.980119,"marketCap":2818192610},{"date":"2021-11-12","current":-9.42017,"twenty":-26.501178,"median":-13.883402,"eighty":-9.642783,"marketCap":3090742560},{"date":"2021-11-19","current":-9.993809,"twenty":-26.445097,"median":-13.875629,"eighty":-9.639623,"marketCap":3274313120},{"date":"2021-11-26","current":-9.93865,"twenty":-26.337858,"median":-13.67475,"eighty":-9.647662,"marketCap":3257283040},{"date":"2021-12-03","current":-10.40565,"twenty":-26.272117,"median":-13.432088,"eighty":-9.665551,"marketCap":3416642270},{"date":"2021-12-10","current":-10.070825,"twenty":-26.190811,"median":-13.356835,"eighty":-9.665551,"marketCap":3312350560},{"date":"2021-12-17","current":-9.235444,"twenty":-26.118235,"median":-13.082869,"eighty":-9.631582,"marketCap":3035489310},{"date":"2021-12-24","current":-9.813413,"twenty":-26.084896,"median":-12.999709,"eighty":-9.575593,"marketCap":3228535530},{"date":"2021-12-31","current":-10.844012,"twenty":-26.065307,"median":-12.934788,"eighty":-9.578506,"marketCap":3575354860},{"date":"2022-01-07","current":-11.844839,"twenty":-13.746537,"median":-11.844839,"eighty":-10.061407,"marketCap":3890507720},{"date":"2022-01-14","current":-13.898995,"twenty":-13.746537,"median":-12.309572,"eighty":-10.552334,"marketCap":4575150140},{"date":"2022-01-21","current":-16.436478,"twenty":-16.916833,"median":-13.314768,"eighty":-11.444508,"marketCap":5422802660},{"date":"2022-01-28","current":-12.515763,"twenty":-15.891088,"median":-13.294428,"eighty":-11.905461,"marketCap":4118721860},{"date":"2022-02-04","current":-12.918373,"twenty":-15.527494,"median":-13.172133,"eighty":-11.945875,"marketCap":4249129940},{"date":"2022-02-11","current":-13.749623,"twenty":-15.527494,"median":-13.643555,"eighty":-12.107031,"marketCap":4531680780},{"date":"2022-02-18","current":-14.699583,"twenty":-15.230713,"median":-13.762166,"eighty":-12.512113,"marketCap":4868568320},{"date":"2022-02-25","current":-14.401585,"twenty":-15.230713,"median":-13.898995,"eighty":-12.515763,"marketCap":4781629600},{"date":"2022-03-04","current":-15.050437,"twenty":-15.15343,"median":-14.35444,"eighty":-12.745602,"marketCap":4998976400},{"date":"2022-03-11","current":-11.829182,"twenty":-15.076137,"median":-14.197144,"eighty":-12.515763,"marketCap":3923109740},{"date":"2022-03-18","current":-18.160245,"twenty":-15.15343,"median":-14.130354,"eighty":-12.512113,"marketCap":5998771680},{"date":"2022-03-25","current":-23.265801,"twenty":-15.804034,"median":-14.369858,"eighty":-12.515763,"marketCap":5694486160},{"date":"2022-04-01","current":-22.572946,"twenty":-18.160245,"median":-14.63199,"eighty":-12.7161,"marketCap":5531476060},{"date":"2022-04-08","current":-23.715707,"twenty":-21.833142,"median":-14.748151,"eighty":-12.739702,"marketCap":5814026900},{"date":"2022-04-14","current":-21.490504,"twenty":-21.683047,"median":-14.849995,"eighty":-12.849265,"marketCap":5259792560},{"date":"2022-04-22","current":-19.863698,"twenty":-21.600394,"median":-14.955439,"eighty":-12.933785,"marketCap":4770762260},{"date":"2022-04-29","current":-19.590787,"twenty":-21.409116,"median":-15.049314,"eighty":-13.002214,"marketCap":4629486840},{"date":"2022-05-06","current":-17.396263,"twenty":-21.270237,"median":-15.076137,"eighty":-13.110961,"marketCap":4076752500},{"date":"2022-05-13","current":-18.610663,"twenty":-21.20305,"median":-15.230713,"eighty":-13.274087,"marketCap":4283307960},{"date":"2022-05-20","current":-18.632644,"twenty":-20.958324,"median":-15.665764,"eighty":-13.314768,"marketCap":4348536000},{"date":"2022-05-27","current":-17.623136,"twenty":-20.880127,"median":-16.522446,"eighty":-13.630838,"marketCap":4109366520},{"date":"2022-06-02","current":-17.853668,"twenty":-20.492571,"median":-17.233543,"eighty":-13.641012,"marketCap":4185465900},{"date":"2022-06-10","current":-18.161257,"twenty":-19.970095,"median":-17.41371,"eighty":-13.669209,"marketCap":4228951260},{"date":"2022-06-17","current":-17.854023,"twenty":-19.645369,"median":-17.431157,"eighty":-13.717329,"marketCap":4152851880},{"date":"2022-06-24","current":-18.109092,"twenty":-19.371762,"median":-17.63025,"eighty":-13.745249,"marketCap":4228951260},{"date":"2022-06-30","current":-17.673991,"twenty":-19.310985,"median":-17.653236,"eighty":-13.764675,"marketCap":4120237860},{"date":"2022-07-08","current":-18.30801,"twenty":-19.310985,"median":-17.673991,"eighty":-13.849281,"marketCap":4272436620},{"date":"2022-07-15","current":-16.316301,"twenty":-19.289141,"median":-17.666899,"eighty":-13.997737,"marketCap":3772354980},{"date":"2022-07-22","current":-16.540555,"twenty":-19.000023,"median":-17.637365,"eighty":-14.143712,"marketCap":3826711680},{"date":"2022-07-29","current":-15.769476,"twenty":-18.747643,"median":-17.569111,"eighty":-14.282271,"marketCap":3652770240},{"date":"2022-08-05","current":-16.327325,"twenty":-18.677534,"median":-17.396263,"eighty":-14.357524,"marketCap":3772354980},{"date":"2022-08-12","current":-16.540049,"twenty":-18.643914,"median":-17.288694,"eighty":-14.388894,"marketCap":3826711680},{"date":"2022-08-19","current":-16.280106,"twenty":-18.622948,"median":-17.233543,"eighty":-14.502281,"marketCap":3728869620},{"date":"2022-08-26","current":-18.968898,"twenty":-18.789197,"median":-17.288694,"eighty":-14.644506,"marketCap":3815840340},{"date":"2022-09-02","current":-16.867763,"twenty":-18.730307,"median":-17.347726,"eighty":-14.697577,"marketCap":3380986740},{"date":"2022-09-09","current":-16.76889,"twenty":-18.677534,"median":-17.249775,"eighty":-14.757865,"marketCap":3348372720},{"date":"2022-09-16","current":-15.716335,"twenty":-18.64955,"median":-17.115151,"eighty":-14.796788,"marketCap":3109203240},{"date":"2022-09-23","current":-15.015443,"twenty":-18.62618,"median":-16.946014,"eighty":-14.839374,"marketCap":2913519120},{"date":"2022-09-30","current":-15.37826,"twenty":-18.614156,"median":-16.751565,"eighty":-14.921103,"marketCap":2989618500},{"date":"2022-10-07","current":-14.819903,"twenty":-18.606636,"median":-16.630085,"eighty":-14.836542,"marketCap":2880905100},{"date":"2022-10-14","current":-13.000449,"twenty":-18.587919,"median":-16.540555,"eighty":-14.695572,"marketCap":2500408200},{"date":"2022-10-21","current":-13.203919,"twenty":-18.5546,"median":-16.521647,"eighty":-14.34519,"marketCap":2522150880},{"date":"2022-10-28","current":-14.480815,"twenty":-18.46151,"median":-16.451964,"eighty":-14.220761,"marketCap":2761320360},{"date":"2022-11-04","current":-17.728963,"twenty":-18.445575,"median":-16.484507,"eighty":-14.220761,"marketCap":3413600760},{"date":"2022-11-11","current":-16.285217,"twenty":-18.404401,"median":-16.520848,"eighty":-14.319989,"marketCap":3163559940},{"date":"2022-11-18","current":-20.103605,"twenty":-18.5546,"median":-16.540302,"eighty":-14.34519,"marketCap":3891939720},{"date":"2022-11-25","current":-17.886989,"twenty":-18.5546,"median":-16.584302,"eighty":-14.376203,"marketCap":3435343440},{"date":"2022-12-02","current":-19.030264,"twenty":-18.606636,"median":-16.684302,"eighty":-14.417431,"marketCap":3717998280},{"date":"2022-12-09","current":-19.130787,"twenty":-18.629412,"median":-16.76889,"eighty":-14.498534,"marketCap":3772354980},{"date":"2022-12-16","current":-20.667558,"twenty":-18.761338,"median":-16.964223,"eighty":-14.594443,"marketCap":4065881160},{"date":"2022-12-23","current":-24.859641,"twenty":-18.956709,"median":-17.233543,"eighty":-14.695572,"marketCap":4892103000},{"date":"2022-12-30","current":-25.871174,"twenty":-19.083574,"median":-17.249775,"eighty":-14.69858,"marketCap":5153015160},{"date":"2023-01-06","current":-25.12186,"twenty":-19.140053,"median":-17.290439,"eighty":-14.757865,"marketCap":5055173100},{"date":"2023-01-13","current":-24.544401,"twenty":-19.323084,"median":-17.396263,"eighty":-14.796822,"marketCap":5033430420},{"date":"2023-01-20","current":-23.420078,"twenty":-19.652908,"median":-17.543878,"eighty":-14.810698,"marketCap":4761646920},{"date":"2023-01-27","current":-23.468747,"twenty":-19.824386,"median":-17.569111,"eighty":-14.819903,"marketCap":4772518260},{"date":"2023-02-03","current":-24.305158,"twenty":-20.244661,"median":-17.636045,"eighty":-14.865105,"marketCap":4968202380},{"date":"2023-02-10","current":-21.134736,"twenty":-20.667558,"median":-17.653236,"eighty":-14.903098,"marketCap":4294179300},{"date":"2023-02-17","current":-19.716053,"twenty":-20.880127,"median":-17.673991,"eighty":-14.948111,"marketCap":3968039100},{"date":"2023-02-24","current":-17.499248,"twenty":-20.667558,"median":-17.683976,"eighty":-14.962767,"marketCap":3478828800},{"date":"2023-03-03","current":-17.930481,"twenty":-20.549416,"median":-17.681738,"eighty":-14.98647,"marketCap":3587542200},{"date":"2023-03-10","current":-16.312167,"twenty":-16.61243,"median":-16.354707,"eighty":-16.246481,"marketCap":3239659320},{"date":"2023-03-17","current":-15.99321,"twenty":-859.547185,"median":-27.214831,"eighty":-15.236448,"marketCap":3207045300},{"date":"2023-03-24","current":-8.158391,"twenty":-857.733696,"median":-27.194813,"eighty":-15.146534,"marketCap":2957004480},{"date":"2023-03-31","current":-7.55624,"twenty":-856.818296,"median":-27.138398,"eighty":-15.059097,"marketCap":2717835000},{"date":"2023-04-06","current":-7.893805,"twenty":-856.073051,"median":-27.078657,"eighty":-15.049314,"marketCap":2837419740},{"date":"2023-04-14","current":-8.61117,"twenty":-855.930861,"median":-27.005778,"eighty":-15.016535,"marketCap":3098331900},{"date":"2023-04-21","current":-7.829618,"twenty":-853.743672,"median":-26.946633,"eighty":-14.959836,"marketCap":2815677060},{"date":"2023-04-28","current":-7.736069,"twenty":-851.842458,"median":-26.911578,"eighty":-14.890978,"marketCap":2761320360},{"date":"2023-05-05","current":-8.453174,"twenty":-850.368239,"median":-26.887993,"eighty":-14.810698,"marketCap":3022232520},{"date":"2023-05-12","current":-7.654484,"twenty":-844.255875,"median":-26.864581,"eighty":-14.748851,"marketCap":2717835000},{"date":"2023-05-19","current":-7.204671,"twenty":-840.637331,"median":-26.809281,"eighty":-14.567812,"marketCap":2522150880},{"date":"2023-05-25","current":-7.047343,"twenty":-839.945996,"median":-26.786513,"eighty":-14.442753,"marketCap":2456922840},{"date":"2023-06-02","current":-5.913628,"twenty":-835.38621,"median":-26.758553,"eighty":-14.376203,"marketCap":2054683260},{"date":"2023-06-09","current":-5.702832,"twenty":-818.129553,"median":-26.710974,"eighty":-14.315719,"marketCap":1978583880},{"date":"2023-06-16","current":-6.044208,"twenty":-802.117148,"median":-26.699006,"eighty":-14.193526,"marketCap":2086980480},{"date":"2023-06-23","current":-5.845382,"twenty":-785.68443,"median":-26.663692,"eighty":-13.898995,"marketCap":2007320300},{"date":"2023-06-30","current":-5.980535,"twenty":-778.272292,"median":-26.61418,"eighty":-13.87645,"marketCap":2035154520},{"date":"2023-07-07","current":-6.605364,"twenty":-429.563707,"median":-26.606395,"eighty":-13.753995,"marketCap":2243396480},{"date":"2023-07-14","current":-6.997294,"twenty":-301.659425,"median":-26.583832,"eighty":-13.673153,"marketCap":2409856960},{"date":"2023-07-21","current":-6.759426,"twenty":-288.581382,"median":-26.525876,"eighty":-13.629373,"marketCap":2317116240},{"date":"2023-07-28","current":-6.234106,"twenty":-276.345263,"median":-26.501017,"eighty":-13.418778,"marketCap":2134750610},{"date":"2023-08-04","current":-5.879734,"twenty":-267.511133,"median":-26.433729,"eighty":-13.322151,"marketCap":2016749320},{"date":"2023-08-11","current":-5.535688,"twenty":-209.927243,"median":-26.317959,"eighty":-13.137257,"marketCap":1888020640},{"date":"2023-08-18","current":-5.702326,"twenty":-206.412816,"median":-26.285946,"eighty":-13.008751,"marketCap":1930930200},{"date":"2023-08-25","current":-8.437208,"twenty":-153.130438,"median":-26.194028,"eighty":-12.926079,"marketCap":2209842340},{"date":"2023-09-01","current":-8.966812,"twenty":-53.382403,"median":-26.066754,"eighty":-12.827356,"marketCap":2358305400},{"date":"2023-09-08","current":-8.927792,"twenty":-49.491615,"median":-25.991719,"eighty":-12.748779,"marketCap":2320400530},{"date":"2023-09-15","current":-7.693984,"twenty":-47.216764,"median":-25.915129,"eighty":-12.699259,"marketCap":2015229510},{"date":"2023-09-22","current":-7.514168,"twenty":-46.322006,"median":-25.798974,"eighty":-12.601365,"marketCap":1959526400},{"date":"2023-09-29","current":-8.005269,"twenty":-45.602151,"median":-25.742295,"eighty":-12.513573,"marketCap":2091174700},{"date":"2023-10-06","current":-7.794811,"twenty":-44.867875,"median":-25.623114,"eighty":-12.464811,"marketCap":2035223040},{"date":"2023-10-13","current":-7.593854,"twenty":-44.174678,"median":-25.459845,"eighty":-12.377739,"marketCap":1979791440},{"date":"2023-10-20","current":-7.173699,"twenty":-43.742069,"median":-24.944313,"eighty":-12.316404,"marketCap":1867371240},{"date":"2023-10-27","current":-7.332259,"twenty":-43.600883,"median":-24.544401,"eighty":-12.227731,"marketCap":1907826880},{"date":"2023-11-03","current":-7.467694,"twenty":-43.226685,"median":-24.305158,"eighty":-11.9436,"marketCap":1948225750},{"date":"2023-11-10","current":-7.539507,"twenty":-42.611945,"median":-23.686985,"eighty":-11.104028,"marketCap":1966549970},{"date":"2023-11-17","current":-7.348049,"twenty":-42.179625,"median":-23.417707,"eighty":-10.369722,"marketCap":1933897040},{"date":"2023-11-24","current":-7.63362,"twenty":-41.40647,"median":-22.798937,"eighty":-10.175003,"marketCap":2025594830},{"date":"2023-12-01","current":-7.277958,"twenty":-40.622269,"median":-22.111475,"eighty":-10.082303,"marketCap":1939227350},{"date":"2023-12-08","current":-6.705384,"twenty":-39.890302,"median":-21.490504,"eighty":-9.976804,"marketCap":1779442700},{"date":"2023-12-15","current":-6.541665,"twenty":-39.34123,"median":-20.977411,"eighty":-9.850148,"marketCap":1746020070},{"date":"2023-12-22","current":-6.098485,"twenty":-38.040839,"median":-20.549416,"eighty":-9.736195,"marketCap":1626644760},{"date":"2023-12-29","current":-5.677286,"twenty":-37.684082,"median":-20.244661,"eighty":-9.647662,"marketCap":1522372660},{"date":"2024-01-05","current":-5.003084,"twenty":-37.205408,"median":-19.863698,"eighty":-9.579458,"marketCap":1332122880},{"date":"2024-01-12","current":-5.31345,"twenty":-36.743617,"median":-19.590787,"eighty":-9.495308,"marketCap":1415514140},{"date":"2024-01-19","current":-5.871801,"twenty":-36.390552,"median":-19.317006,"eighty":-9.4536,"marketCap":1562111600},{"date":"2024-01-26","current":-6.568447,"twenty":-36.077009,"median":-19.153952,"eighty":-9.378434,"marketCap":1740643600},{"date":"2024-02-02","current":-6.549533,"twenty":-35.939845,"median":-19.030264,"eighty":-9.332778,"marketCap":1733418600},{"date":"2024-02-09","current":-6.6813,"twenty":-35.587972,"median":-18.817772,"eighty":-9.258152,"marketCap":1777000750},{"date":"2024-02-16","current":-7.015472,"twenty":-35.201054,"median":-18.681712,"eighty":-9.243388,"marketCap":1866282560},{"date":"2024-02-23","current":-6.965496,"twenty":-34.904271,"median":-18.584004,"eighty":-9.15982,"marketCap":1843219560},{"date":"2024-03-01","current":-6.578674,"twenty":-34.762406,"median":-18.393775,"eighty":-9.048962,"marketCap":1741943760},{"date":"2024-03-08","current":-6.116976,"twenty":-34.291324,"median":-18.358603,"eighty":-8.989107,"marketCap":1620412800},{"date":"2024-03-15","current":-6.31372,"twenty":-34.169695,"median":-18.286774,"eighty":-8.966068,"marketCap":1671050700},{"date":"2024-03-22","current":-6.0897,"twenty":-34.007358,"median":-18.165862,"eighty":-8.908417,"marketCap":1610285220},{"date":"2024-03-28","current":-9.241453,"twenty":-33.918806,"median":-18.128877,"eighty":-8.893205,"marketCap":1448243940},{"date":"2024-04-05","current":-8.536193,"twenty":-33.589784,"median":-18.065512,"eighty":-8.838523,"marketCap":1336840560},{"date":"2024-04-12","current":-8.272823,"twenty":-33.35649,"median":-17.939408,"eighty":-8.727145,"marketCap":1296330240},{"date":"2024-04-19","current":-8.279892,"twenty":-33.174366,"median":-17.853668,"eighty":-8.605272,"marketCap":1296330240},{"date":"2024-04-26","current":-8.678713,"twenty":-33.059884,"median":-17.759229,"eighty":-8.524743,"marketCap":1357095720},{"date":"2024-05-03","current":-9.203206,"twenty":-32.801614,"median":-17.687796,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-10","current":-9.181408,"twenty":-32.632919,"median":-17.661614,"eighty":-8.477563,"marketCap":1438116360},{"date":"2024-05-17","current":-8.741635,"twenty":-32.551122,"median":-17.623136,"eighty":-8.477563,"marketCap":1367223300},{"date":"2024-05-24","current":-8.177535,"twenty":-32.325579,"median":-17.539325,"eighty":-8.449981,"marketCap":1276075080},{"date":"2024-05-31","current":-7.845046,"twenty":-32.033995,"median":-17.347726,"eighty":-8.385666,"marketCap":1225437180},{"date":"2024-06-07","current":-7.400377,"twenty":-31.809988,"median":-17.233543,"eighty":-8.298959,"marketCap":1154544120},{"date":"2024-06-14","current":-6.887364,"twenty":-31.578107,"median":-16.935206,"eighty":-8.273349,"marketCap":1073523480},{"date":"2024-06-21","current":-5.860029,"twenty":-31.347447,"median":-16.734241,"eighty":-8.218166,"marketCap":911482200},{"date":"2024-06-28","current":-5.211077,"twenty":-31.228256,"median":-16.576517,"eighty":-8.179208,"marketCap":810206400},{"date":"2024-07-05","current":-6.059193,"twenty":-31.009798,"median":-16.520848,"eighty":-8.127037,"marketCap":941864940},{"date":"2024-07-12","current":-6.115326,"twenty":-30.76933,"median":-16.436478,"eighty":-8.062904,"marketCap":951986880},{"date":"2024-07-19","current":-7.004141,"twenty":-30.557099,"median":-16.340035,"eighty":-8.028781,"marketCap":1090371240},{"date":"2024-07-26","current":-7.669327,"twenty":-30.166665,"median":-16.305518,"eighty":-7.995559,"marketCap":1198359750},{"date":"2024-08-02","current":-6.796557,"twenty":-29.911296,"median":-16.197141,"eighty":-7.891041,"marketCap":1061367400},{"date":"2024-08-09","current":-5.605068,"twenty":-29.68082,"median":-16.109649,"eighty":-7.860985,"marketCap":881135200},{"date":"2024-08-16","current":-5.284545,"twenty":-29.399025,"median":-16.004915,"eighty":-7.841452,"marketCap":831070700},{"date":"2024-08-23","current":-4.945296,"twenty":-29.313204,"median":-15.849402,"eighty":-7.79201,"marketCap":781006200},{"date":"2024-08-30","current":-5.353167,"twenty":-29.110493,"median":-15.769476,"eighty":-7.728882,"marketCap":851096500},{"date":"2024-09-06","current":-3.418622,"twenty":-28.890701,"median":-15.662682,"eighty":-7.666358,"marketCap":971251300},{"date":"2024-09-13","current":-3.060869,"twenty":-28.749884,"median":-15.561249,"eighty":-7.617596,"marketCap":867335190},{"date":"2024-09-20","current":-3.483773,"twenty":-28.561104,"median":-15.420271,"eighty":-7.598347,"marketCap":993090000},{"date":"2024-09-27","current":-3.760093,"twenty":-28.333146,"median":-15.365842,"eighty":-7.561653,"marketCap":1078304300},{"date":"2024-10-04","current":-4.747552,"twenty":-28.250282,"median":-15.319205,"eighty":-7.535461,"marketCap":1355299900},{"date":"2024-10-10","current":-4.708735,"twenty":-28.130154,"median":-15.28172,"eighty":-7.522101,"marketCap":1335514500},{"date":"2024-10-18","current":-4.628229,"twenty":-28.007466,"median":-15.211834,"eighty":-7.460943,"marketCap":1305836400},{"date":"2024-10-25","current":-4.787628,"twenty":-27.863809,"median":-15.071389,"eighty":-7.420411,"marketCap":1350724680},{"date":"2024-11-01","current":-4.888412,"twenty":-27.732043,"median":-15.043947,"eighty":-7.390073,"marketCap":1380088260},{"date":"2024-11-08","current":-5.393498,"twenty":-27.592224,"median":-14.969216,"eighty":-7.334181,"marketCap":1515776000},{"date":"2024-11-15","current":-5.694569,"twenty":-27.430791,"median":-14.889359,"eighty":-7.267767,"marketCap":1583441460},{"date":"2024-11-22","current":-6.224792,"twenty":-27.252497,"median":-14.784149,"eighty":-7.20416,"marketCap":1730056410},{"date":"2024-11-29","current":-5.401652,"twenty":-27.149392,"median":-14.63199,"eighty":-7.145452,"marketCap":1500274450},{"date":"2024-12-06","current":-6.462356,"twenty":-26.958966,"median":-14.415446,"eighty":-7.084264,"marketCap":1790650150},{"date":"2024-12-13","current":-7.525158,"twenty":-26.898699,"median":-14.328346,"eighty":-7.042598,"marketCap":2081025850},{"date":"2024-12-20","current":-9.773511,"twenty":-26.831826,"median":-14.194883,"eighty":-7.042598,"marketCap":2690814820},{"date":"2024-12-27","current":-10.308856,"twenty":-26.785545,"median":-13.98128,"eighty":-7.042598,"marketCap":2836002670},{"date":"2025-01-03","current":-11.036911,"twenty":-26.724476,"median":-13.876142,"eighty":-7.042598,"marketCap":3039265660},{"date":"2025-01-10","current":-10.090962,"twenty":-26.659448,"median":-13.738689,"eighty":-7.042598,"marketCap":2768248340},{"date":"2025-01-17","current":-13.505837,"twenty":-26.604626,"median":-13.644863,"eighty":-7.042598,"marketCap":3708038950},{"date":"2025-01-24","current":-14.258417,"twenty":-26.513964,"median":-13.644863,"eighty":-7.042598,"marketCap":3939189430},{"date":"2025-01-28","current":-14.045364,"twenty":-26.50266,"median":-13.646172,"eighty":-7.044971,"marketCap":3900664350},{"date":"2025-02-07","current":-14.613563,"twenty":-26.385453,"median":-13.643555,"eighty":-7.040226,"marketCap":4035502130},{"date":"2025-02-14","current":-14.027409,"twenty":-26.305488,"median":-13.643555,"eighty":-7.040226,"marketCap":3871770540},{"date":"2025-02-21","current":-20.966333,"twenty":-26.268748,"median":-13.643555,"eighty":-7.040226,"marketCap":5807655810},{"date":"2025-02-28","current":-23.024105,"twenty":-26.124527,"median":-13.643555,"eighty":-7.040226,"marketCap":6356638200},{"date":"2025-03-07","current":-23.948261,"twenty":-26.021583,"median":-13.637196,"eighty":-7.037853,"marketCap":6638331300},{"date":"2025-03-14","current":-27.478442,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7619649840},{"date":"2025-03-21","current":-28.63462,"twenty":-25.994745,"median":-13.637196,"eighty":-7.037853,"marketCap":7937135250},{"date":"2025-03-28","current":-22.254415,"twenty":-25.981622,"median":-13.637196,"eighty":-7.037853,"marketCap":7167473650},{"date":"2025-04-03","current":-19.455031,"twenty":-25.920491,"median":-13.637196,"eighty":-7.037853,"marketCap":6253500500},{"date":"2025-04-11","current":-16.143826,"twenty":-25.799935,"median":-13.637196,"eighty":-7.037853,"marketCap":5154695920},{"date":"2025-04-17","current":-14.844692,"twenty":-25.761244,"median":-13.643555,"eighty":-7.040226,"marketCap":4751255705},{"date":"2025-04-25","current":-18.855479,"twenty":-25.629177,"median":-13.630838,"eighty":-7.035481,"marketCap":6040177180},{"date":"2025-05-02","current":-19.624433,"twenty":-25.555188,"median":-13.637196,"eighty":-7.037853,"marketCap":6299866327},{"date":"2025-05-09","current":-19.687295,"twenty":-25.378575,"median":-13.630838,"eighty":-7.035481,"marketCap":6364413943},{"date":"2025-05-16","current":-16.189425,"twenty":-25.028984,"median":-13.630838,"eighty":-7.035481,"marketCap":5276397641},{"date":"2025-05-23","current":-19.381154,"twenty":-24.642413,"median":-13.630838,"eighty":-7.035481,"marketCap":6335528555},{"date":"2025-05-30","current":-22.492822,"twenty":-24.315979,"median":-13.630838,"eighty":-7.035481,"marketCap":7385031005},{"date":"2025-06-06","current":-22.37708,"twenty":-24.163622,"median":-13.630838,"eighty":-7.035481,"marketCap":7365774080},{"date":"2025-06-13","current":-27.602111,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9089268930},{"date":"2025-06-20","current":-28.183664,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":9262581261},{"date":"2025-06-27","current":-25.15423,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8290106513},{"date":"2025-07-04","current":-27.519363,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9070012004},{"date":"2025-07-11","current":-25.909492,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":8530818085},{"date":"2025-07-18","current":-34.00727,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11188273831},{"date":"2025-07-25","current":-31.259636,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10321712175},{"date":"2025-08-01","current":-30.808479,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10109885992},{"date":"2025-08-08","current":-40.038892,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13171737178},{"date":"2025-08-15","current":-51.999696,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17080893095},{"date":"2025-08-22","current":-50.820081,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14298267332},{"date":"2025-08-29","current":-48.026994,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13576938778},{"date":"2025-09-05","current":-47.125793,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13308972881},{"date":"2025-09-12","current":-39.078151,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":11056074414},{"date":"2025-09-19","current":-37.494834,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10600591060},{"date":"2025-09-26","current":-36.39561,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":10263119060},{"date":"2025-10-03","current":-37.842129,"twenty":-24.207039,"median":-13.643555,"eighty":-7.040226,"marketCap":10696487426},{"date":"2025-10-10","current":-33.495493,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9454067526},{"date":"2025-10-17","current":-32.00426,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9026136568},{"date":"2025-10-24","current":-32.086576,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9052642598},{"date":"2025-10-31","current":-33.892495,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9576412188},{"date":"2025-11-07","current":-33.200765,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":9375102324},{"date":"2025-11-14","current":-48.131606,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13629727156},{"date":"2025-11-21","current":-46.471802,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13153579483},{"date":"2025-11-28","current":-51.08762,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14512584301},{"date":"2025-12-05","current":-47.583674,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":13540449468},{"date":"2025-12-12","current":-50.523029,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":14403467126},{"date":"2025-12-19","current":-45.12776,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12895666160},{"date":"2025-12-24","current":-43.638002,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":12508796175},{"date":"2026-01-02","current":-39.705675,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":11426392166},{"date":"2026-01-09","current":-43.068244,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":12424923948},{"date":"2026-01-16","current":-45.622443,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":13204565721},{"date":"2026-01-23","current":-48.737975,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":14092765209},{"date":"2026-01-30","current":-46.885388,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":13619058816},{"date":"2026-02-06","current":-51.771469,"twenty":-24.118715,"median":-13.630838,"eighty":-7.035481,"marketCap":15076489664},{"date":"2026-02-13","current":-59.490106,"twenty":-24.154641,"median":-13.637196,"eighty":-7.037853,"marketCap":17423759854},{"date":"2026-02-20","current":-64.074951,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":18739561451},{"date":"2026-02-27","current":-56.560964,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":16723413843},{"date":"2026-03-06","current":-52.10008,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":15280276608},{"date":"2026-03-13","current":-53.661958,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":15810841768},{"date":"2026-03-20","current":-51.190704,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":15025605331},{"date":"2026-03-27","current":-61.10711,"twenty":-24.053778,"median":-13.627175,"eighty":-7.032732,"marketCap":17890657195},{"date":"2026-04-02","current":-44.005654,"twenty":-24.24317,"median":-13.654723,"eighty":-7.032732,"marketCap":18017992833},{"date":"2026-04-10","current":-46.163477,"twenty":-24.310583,"median":-13.698366,"eighty":-7.032732,"marketCap":19047289244},{"date":"2026-04-17","current":-47.506573,"twenty":-24.564003,"median":-13.764979,"eighty":-7.032732,"marketCap":19609688313},{"date":"2026-04-24","current":-49.226153,"twenty":-24.847489,"median":-13.877482,"eighty":-7.032732,"marketCap":20320645628},{"date":"2026-04-30","current":-42.326205,"twenty":-25.116962,"median":-13.944088,"eighty":-7.032732,"marketCap":17476816370},{"date":"2026-05-08","current":-43.383478,"twenty":-25.505301,"median":-14.027409,"eighty":-7.029983,"marketCap":17975547620},{"date":"2026-05-15","current":-42.758813,"twenty":-25.770568,"median":-14.155965,"eighty":-7.029983,"marketCap":17763321556},{"date":"2026-05-22","current":-39.963799,"twenty":-25.921778,"median":-14.250125,"eighty":-7.032732,"marketCap":16564244295},{"date":"2026-05-29","current":-36.312792,"twenty":-26.163952,"median":-14.258417,"eighty":-7.029983,"marketCap":15103307124},{"date":"2026-06-05","current":-26.704606,"twenty":-26.299383,"median":-14.258417,"eighty":-7.029983,"marketCap":11123166455},{"date":"2026-06-12","current":-25.549739,"twenty":-26.299383,"median":-14.258417,"eighty":-7.029983,"marketCap":10634935866},{"date":"2026-06-18","current":-24.878081,"twenty":-26.296353,"median":-14.270376,"eighty":-7.032732,"marketCap":10380206864},{"date":"2026-06-26","current":-24.846794,"twenty":-26.299383,"median":-14.258417,"eighty":-7.029983,"marketCap":10316524613},{"date":"2026-07-03","current":-29.477126,"twenty":-26.506386,"median":-14.258417,"eighty":-7.029983,"marketCap":12248219551},{"date":"2026-07-10","current":-28.567077,"twenty":-26.865664,"median":-14.258417,"eighty":-7.029983,"marketCap":11855512338},{"date":"2026-07-17","current":-21.330218,"twenty":-26.991328,"median":-14.258417,"eighty":-7.029983,"marketCap":8883673972},{"date":"2026-07-24","current":-22.981523,"twenty":-26.991328,"median":-14.339023,"eighty":-7.029983,"marketCap":9573565021},{"date":"2026-07-31","current":-21.234131,"twenty":-26.998612,"median":-14.501974,"eighty":-7.027235,"marketCap":8862446555},{"date":"2026-08-07","current":-28.324989,"twenty":-27.013495,"median":-14.735581,"eighty":-7.027235,"marketCap":11844898630},{"date":"2026-08-14","current":-26.615787,"twenty":-27.063443,"median":-14.832297,"eighty":-7.027235,"marketCap":11144237664},{"date":"2026-08-21","current":-25.222949,"twenty":-27.063443,"median":-14.898373,"eighty":-7.027235,"marketCap":10584384966},{"date":"2026-08-28","current":-25.418566,"twenty":-27.063443,"median":-14.989061,"eighty":-7.027235,"marketCap":10668891034},{"date":"2026-09-04","current":-15.441023,"twenty":-27.063443,"median":-15.049876,"eighty":-7.027235,"marketCap":10658327776},{"date":"2026-09-10","current":-15.359083,"twenty":-27.063443,"median":-15.125792,"eighty":-7.027235,"marketCap":10616074742}],"updateTime":1789127933470},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01672\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2630456396","title":"Sagimet Biosciences Shares Rise With Focus on Acne Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2630456396","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630456396?lang=en_us&edition=fundamental","pubTime":"2026-04-27 20:02","pubTimestamp":1777291320,"startTime":"0","endTime":"0","summary":"Sagimet Biosciences shares rose after the company said it would focus on advancing development of its acne treatment in the U.S.The stock climbed 29% to $7.55 in premarket trading Monday. Through Friday's close, the stock had ticked down 1% this year.The clinical-stage biopharmaceutical company said it plans to start a U.S. Phase 3 trial of denifanstat, a treatment for moderate to severe acne, in the second half of this year.The decision marks a broader strategic shift to prioritize Sagimet's dermatology business while pursuing nondilutive funding options for its program in the liver disease MASH, or metabolic dysfunction-associated steatohepatitis, Chief Financial Officer Thierry Chauche said.Sagimet had also been developing a combination of denifanstat and resmetirom to treat MASH. The company reported the completion of a Phase 1 trial in December 2025, and expects the combination treatment to be ready for a Phase 2 trial in the second half of this year.In January, Sagimet's license ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1515","BK4139","SGMT","BK1161","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164887151","title":"ASCLETIS-B Completes Patient Enrollment for US Phase II Trial of Oral GLP-1R Agonist ASC30 in Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=1164887151","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164887151?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:12","pubTimestamp":1777248751,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced that patient enrollment has been completed for its 13-week US Phase II clinical study (NCT07321678) evaluating the oral small-molecule GLP-1 receptor agonist ASC30...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","GLP","BK1161","BK4590","BK1574","BK4144","01477","BK1515","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630327603","title":"Ascletis Completes Enrollment in U.S. Phase Ii Study of Asc30, an Oral Small Molecule Glp-1R Agonist, for the Treatment of Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2630327603","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630327603?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:10","pubTimestamp":1777248600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nTUA8CYJT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","01672","BK1515","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630332946","title":"Ascletis completes enrollment in US Phase II diabetes trial of oral GLP-1 drug ASC30","url":"https://stock-news.laohu8.com/highlight/detail?id=2630332946","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2630332946?lang=en_us&edition=fundamental","pubTime":"2026-04-27 08:00","pubTimestamp":1777248041,"startTime":"0","endTime":"0","summary":"Ascletis completed enrollment in a 13-week U.S. Phase II trial of ASC30, its once-daily oral small-molecule GLP-1 receptor agonist, in 100 patients with type 2 diabetes.Topline results have not been presented yet; data are expected in Q3 2026.Trial is designed to assess whether ASC30 can improve blood sugar control versus placebo, with additional readouts on weight change and overall safety.Program expansion adds a second major indication for ASC30 beyond obesity, positioning it for a larger metabolic disease market opportunity.Ascletis expects to seek FDA clearance to start U.S. Phase III trials in obesity by end-Q3 2026, following previously disclosed Phase II obesity results from December 2025.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260427:nNDL1rys5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190075292","title":"ASCLETIS-B Shares Surge Over 4% in Morning Session as Key Pipeline Drug ASC30 Nears Phase III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1190075292","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190075292?lang=en_us&edition=fundamental","pubTime":"2026-04-24 11:14","pubTimestamp":1777000467,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) rose more than 4% in morning trading. At the time of writing, the stock was up 3.46% to HK$18.82, with a turnover of HK$21.991 million. The company previously announced the...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1574","BK1191","01672","BK1515","BK1161","BK4588","III","VXUS","01477","BK4585","BK4134"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165196464","title":"HK Biotech Stocks Fell. Akeso Down 12%; Remegen, Zai Lab, KeyMed And Junshi Down 7%; Lepu And Innocare Down 6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1165196464","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165196464?lang=en_us&edition=fundamental","pubTime":"2026-04-23 11:32","pubTimestamp":1776915127,"startTime":"0","endTime":"0","summary":"HK biotech stocks fell. Akeso down 12%; Remegen, Zai Lab, KeyMed and Junshi down 7%; Lepu and Innocare down 6%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","02162","06606","09606","09995","06978","02269","02137","02359","09926","03347","01672","09966","09688","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628531347","title":"Assessing Ascletis Pharma (SEHK:1672) Valuation After ASC30_39 Obesity Candidate Advances Toward FDA IND Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2628531347","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2628531347?lang=en_us&edition=fundamental","pubTime":"2026-04-18 21:05","pubTimestamp":1776517538,"startTime":"0","endTime":"0","summary":"Ascletis Pharma (SEHK:1672) announced the selection of its ASC30_39 fixed dose combination obesity therapy candidate for clinical development. The company plans to file an IND with the U.S. FDA in the third quarter of 2026.\nSee our latest analysis for Ascletis Pharma.\nThat obesity announcement comes after a strong run in the shares, with the latest price at HK$18.48, a 30 day share price return of 25.03% and a 1 year total shareholder return of 274.09%. This suggests momentum has been...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-asc3039-o","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/assessing-ascletis-pharma-sehk1672-valuation-after-asc3039-o","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LABU","BK1574","BK1515","01672","IND","BK1161","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1102730668","title":"ASCLETIS-B Nears Previous Peak, But Why Are Investors Staying on the Sidelines?","url":"https://stock-news.laohu8.com/highlight/detail?id=1102730668","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1102730668?lang=en_us&edition=fundamental","pubTime":"2026-04-18 12:46","pubTimestamp":1776487561,"startTime":"0","endTime":"0","summary":"Since October of last year, the Hong Kong stock market's pharmaceutical sector has undergone a significant correction. Initially, this downturn was primarily driven by waning market sentiment and...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1161","01672","BK1574","01477","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195869971","title":"ASCLETIS-B Shares Surge Nearly 5% in Afternoon Trading, Approaching All-Time High as GLP-1 and Amylin Combo Enters Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=1195869971","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195869971?lang=en_us&edition=fundamental","pubTime":"2026-04-17 14:34","pubTimestamp":1776407662,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) rose nearly 5% in afternoon trading, reaching a high of HK$18.68, close to its historical peak of HK$18.75. At the time of writing, the stock was up 4.73% to HK$18.6, with a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","GLP","01672","BK4588","BK4590","BK1191","01477","BK1574","BK4585","VXUS","BK4144"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626597860","title":"Analysts Are Optimistic We'll See A Profit From Ascletis Pharma Inc. (HKG:1672)","url":"https://stock-news.laohu8.com/highlight/detail?id=2626597860","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626597860?lang=en_us&edition=fundamental","pubTime":"2026-04-09 06:22","pubTimestamp":1775686966,"startTime":"0","endTime":"0","summary":"With the business potentially at an important milestone, we thought we'd take a closer look at Ascletis Pharma Inc.'s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/analysts-are-optimistic-well-see-a-profit-from-ascletis-phar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1672/ascletis-pharma-shares/news/analysts-are-optimistic-well-see-a-profit-from-ascletis-phar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1161","BK4139","BK1574","BK1515","ASCLF","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188086618","title":"ASCLETIS-B Maintains Stable Share Base in March; No New Issuance, Public Float Fully Compliant","url":"https://stock-news.laohu8.com/highlight/detail?id=1188086618","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188086618?lang=en_us&edition=fundamental","pubTime":"2026-04-08 12:21","pubTimestamp":1775622107,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. (ASCLETIS-B) released its Monthly Return for Equity Issuers covering March 2026, confirming a month of capital stability with no new share issuance or treasury-share movements....","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1196500897","title":"ASCLETIS-B Advances Clinical Development of Fixed-Dose Combination ASC30_39 for Obesity Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=1196500897","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1196500897?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:36","pubTimestamp":1775561787,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced the selection of ASC30_39 FDC, a fixed-dose combination of once-daily oral small molecule GLP-1 receptor agonist ASC30 and once-daily oral small molecule...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1161","01672","BK4144","BK1574","GLP","01477","BK4590","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625693214","title":"BRIEF-Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinical Development","url":"https://stock-news.laohu8.com/highlight/detail?id=2625693214","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625693214?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:10","pubTimestamp":1775560200,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Announces Fixed-Dose Combination of ASC30, Once-Daily Oral Small Molecule GLP-1R Agonist, and ASC39, Once-Daily Oral Small Molecule Amylin-Selective Amylin Receptor Agonist, for Clinica","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA8DXLG9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1161","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155993644","title":"Ascletis Accelerates Obesity Pipeline with First-in-Class Oral GLP-1/Amylin Fixed-Dose Combo; IND Targeted for Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1155993644","media":"Bulletin Express","labels":["productRelease","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155993644?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:05","pubTimestamp":1775559935,"startTime":"0","endTime":"0","summary":"Ascletis Pharma Inc. (Ascletis) has advanced its obesity franchise by selecting a fixed-dose combination (FDC) tablet—ASC30_39—for clinical development. The one-pill, once-daily regimen co-formulates...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625932323","title":"Ascletis Pharma Inc - Expects Ind Submission to FDA for Asc30_39 Fdc in Q3 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2625932323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625932323?lang=en_us&edition=fundamental","pubTime":"2026-04-07 19:00","pubTimestamp":1775559600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nTUA8DXLG9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1574","01672","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625934718","title":"Ascletis targets Q3 2026 FDA IND filing for oral obesity combo ASC30_39 tablet","url":"https://stock-news.laohu8.com/highlight/detail?id=2625934718","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2625934718?lang=en_us&edition=fundamental","pubTime":"2026-04-07 18:51","pubTimestamp":1775559108,"startTime":"0","endTime":"0","summary":"Ascletis selected ASC30_39, fixed-dose oral combination of ASC30 and ASC39, for clinical development as a once-daily obesity therapy.Preclinical dosing in dogs showed combination tablets performed in line with each drug given alone, supporting use as a single-pill regimen.Compatibility work indicated formulation stability at room temperature, supporting practical manufacturing and distribution.Ascletis expects to file a US FDA IND for ASC30_39 tablets in Q3 2026.No clinical trial results were presented; development update centered on preclinical findings and planned regulatory filing.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ascletis Pharma Inc. published the original content used to generate this news brief via IIS, the Issuer I","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260407:nNDL1GrDdR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK1574","01672","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624656901","title":"Ascletis Pharma's Loss Widens 20% in 2025; Shares Rise 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624656901","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624656901?lang=en_us&edition=fundamental","pubTime":"2026-04-01 13:02","pubTimestamp":1775019764,"startTime":"0","endTime":"0","summary":"Ascletis Pharma's  loss attributable to equity shareholders came in at 359.9 million yuan for 2025, widening 20% from 300.9 million yuan a year earlier, according to a Tuesday Hong Kong bourse filing.Shares of the pharmaceutical firm were up over 5% in Wednesday's midday trade.Loss per share came in at 0.3701 yuan, compared with 0.3005 yuan in the prior year.Total income rose 5.2% to 127.4 million yuan from 121.1 million yuan in 2024.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1574","01672","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624539658","title":"BRIEF-Ascletis Pharma FY Loss Attributable Rmb359.9 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2624539658","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2624539658?lang=en_us&edition=fundamental","pubTime":"2026-04-01 00:45","pubTimestamp":1774975539,"startTime":"0","endTime":"0","summary":"BRIEF-Ascletis Pharma FY Loss Attributable Rmb359.9 MillionMarch 31 (Reuters) - Ascletis Pharma Inc 1672.HK:ASCLETIS PHARMA INC - FY LOSS ATTRIBUTABLE RMB359.9 MILLIONFurther company coverage: 1672.HK ((Reuters.Briefs@thomsonreuters.com;))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01672","BK1515","BK1161","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165768804","title":"ASCLETIS-B Reports Annual Loss Attributable to Shareholders of 360 Million Yuan, Widening 19.6% Year-on-Year","url":"https://stock-news.laohu8.com/highlight/detail?id=1165768804","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165768804?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:36","pubTimestamp":1774967774,"startTime":"0","endTime":"0","summary":"ASCLETIS-B (01672) has announced its annual results for the period ended December 31, 2025. The group recorded total revenue of 127 million Chinese yuan, representing a 5.2% increase compared to the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01477","BK1191","BK1574","BK1515","01672","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623580984","title":"Ascletis Pharma Inc - FY Loss Attributable RMB359.9 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2623580984","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2623580984?lang=en_us&edition=fundamental","pubTime":"2026-03-31 22:18","pubTimestamp":1774966712,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260331:nFWN40J1FZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1161","BK1515","BK1574","01672"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":8,"totalSize":169,"code":"91000000","status":"200"}]}}